MX2008014287A - Mirtazapina para el tratamiento del dolor neuropatico. - Google Patents

Mirtazapina para el tratamiento del dolor neuropatico.

Info

Publication number
MX2008014287A
MX2008014287A MX2008014287A MX2008014287A MX2008014287A MX 2008014287 A MX2008014287 A MX 2008014287A MX 2008014287 A MX2008014287 A MX 2008014287A MX 2008014287 A MX2008014287 A MX 2008014287A MX 2008014287 A MX2008014287 A MX 2008014287A
Authority
MX
Mexico
Prior art keywords
mirtazapine
treatment
pain
neuropathic pain
neuropathic
Prior art date
Application number
MX2008014287A
Other languages
English (en)
Spanish (es)
Inventor
Andrea Houghton
Gerardus Stephanus Franciscus Ruigt
Original Assignee
Organon Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Organon Nv filed Critical Organon Nv
Publication of MX2008014287A publication Critical patent/MX2008014287A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants

Landscapes

  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Neurosurgery (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Pain & Pain Management (AREA)
  • Psychiatry (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
MX2008014287A 2006-05-22 2007-05-21 Mirtazapina para el tratamiento del dolor neuropatico. MX2008014287A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP06114316 2006-05-22
PCT/EP2007/054872 WO2007135123A2 (en) 2006-05-22 2007-05-21 Mirtazapine for the treatment of neuropathic pain

Publications (1)

Publication Number Publication Date
MX2008014287A true MX2008014287A (es) 2008-11-18

Family

ID=37006417

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2008014287A MX2008014287A (es) 2006-05-22 2007-05-21 Mirtazapina para el tratamiento del dolor neuropatico.

Country Status (8)

Country Link
EP (1) EP2026814A2 (enExample)
JP (1) JP2009537601A (enExample)
AR (1) AR061046A1 (enExample)
CA (1) CA2651607A1 (enExample)
MX (1) MX2008014287A (enExample)
PE (1) PE20080455A1 (enExample)
TW (1) TW200808804A (enExample)
WO (1) WO2007135123A2 (enExample)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP6452954B2 (ja) * 2013-05-16 2019-01-16 国立大学法人千葉大学 癌転移抑制剤
PL3261645T3 (pl) 2015-02-27 2021-12-06 Dechra Limited Pobudzanie apetytu, zarządzanie utratą masy ciała, i leczenie anoreksji u psów i kotów

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6211171B1 (en) * 1998-05-19 2001-04-03 Dalhousie University Use of antidepressants for local analgesia
HUP0204050A3 (en) * 2000-01-19 2004-09-28 Akzo Nobel Nv Drug combination for the treatment of depression and related disorders comprising mirtazapine and gepirone
US7074961B2 (en) * 2000-09-26 2006-07-11 The Brigham And Women's Hospital, Inc. Antidepressants and their analogues as long-acting local anesthetics and analgesics
UA83666C2 (ru) * 2003-07-10 2008-08-11 Н.В. Органон Способ получения энантиомерно чистого миртазапина
TW200538100A (en) * 2004-04-21 2005-12-01 Akzo Nobel Nv Mirtazapine salts

Also Published As

Publication number Publication date
TW200808804A (en) 2008-02-16
EP2026814A2 (en) 2009-02-25
WO2007135123A3 (en) 2008-03-13
JP2009537601A (ja) 2009-10-29
CA2651607A1 (en) 2007-11-29
WO2007135123A2 (en) 2007-11-29
AR061046A1 (es) 2008-07-30
PE20080455A1 (es) 2008-06-25

Similar Documents

Publication Publication Date Title
Schug et al. Neuraxial drug administration: a review of treatment options for anaesthesia and analgesia
Zink et al. Benefit-risk assessment of ropivacaine in the management of postoperative pain
Weinbroum et al. Dextromethorphan and dexmedetomidine: new agents for the control of perioperative pain
US6936601B2 (en) Compositions for treating pain
CN1132581C (zh) 含米尔塔扎平和一种或多种选择性5－羟色胺再摄取抑制剂的药物组合物
Yazigi et al. Prophylactic ondansetron is effective in the treatment of nausea and vomiting but not on pruritus after cesarean delivery with intrathecal sufentanil-morphine
Buckenmaier III et al. Anaesthetic agents for advanced regional anaesthesia: a North American perspective
US11285099B2 (en) Topical phenytoin for use in the treatment of peripheral neuropathic pain
Kumar Batra et al. Bupivacaine/ketamine is superior to intra-articu-lar ketamine analgesia following arthroscopic knee surgery
Fournier et al. Intrathecal sufentanil is more potent than intravenous for postoperative analgesia after total-hip replacement
Chinachoti et al. Periarticular infiltration of 0.25% bupivacaine on top of femoral nerve block and intrathecal morphine improves quality of pain control after total knee arthroplasty: a randomized double-blind placebo controlled clinical trial
Dahl et al. Immediate and prolonged effects of pre–versus postoperative epidural analgesia with bupivacaine and morphine on pain at rest and during mobilisation after total knee arthroplasty
KR101971412B1 (ko) 정맥 내 투여용 이부프로펜의 투여
Bufalari et al. Preemptive carprofen for peri-operative analgesia in dogs undergoing Tibial Plateau Leveling Osteotomy (TPLO): a prospective, randomized, blinded, placebo controlled clinical trial
Fann Pharmacotherapy in older depressed patients
MX2008014287A (es) Mirtazapina para el tratamiento del dolor neuropatico.
CN1816335A (zh) 治疗超重或倾向于超重的患者精神分裂症的阿森那平
Mohammed et al. Intrathecal versus intravenous dexmedetomidine in characteristics of bupivacaine spinal block in lower abdominal surgery
US20070270413A1 (en) Mirtazapine for the treatment of neuropathic pain
Nimmo et al. Effect of anaesthesia and surgery on pharmacokinetics and pharmacodvamics
Hung et al. Cutaneous analgesia and systemic toxicity of carbetapentane and caramiphen in rats
Jolly et al. Ketamine-current uses and future perspectives
Johnson Treatment of acute pain in cats
Abdelaziz et al. “Preoperative oral duloxetine: does it affect duration of spinal anesthesia and early postoperative pain after arthroscopic ACL repair?” A prospective, randomized, double-blind controlled trial
Freeman Newer agents for the treatment of painful diabetic peripheral neuropathy

Legal Events

Date Code Title Description
FA Abandonment or withdrawal